On October 16, Hims & Hers Health Inc. rose 5.43% in Regular Trading, trading near $29.45 per share, with turnover of $330 million.
The move coincided with renewed market focus on the companys Australia expansion after it launched the Hers womens health platform there, rebranding the existing Juniper service and broadening offerings into hair regrowth, menopause and perimenopause, and weight management.
The rollout followed Hims & Hers Health Inc.s earlier acquisition of Australian digital health company Eucalyptus. The company said existing Juniper patients would keep receiving care from the same local team while gaining access to a broader set of specialties, medication, nutrition and fitness support, and around-the-clock care access. The latest rise suggests investors were reassessing the growth opportunity tied to brand integration and category expansion in that market.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments